Kogan Liron, Menczer Joseph, Shejter Eduardo, Liphshitz Irena, Barchana Micha
Department of Obstetrics and Gynecology, Hebrew University-Hadassah Medical Center (Ein Kerem Campus), Jerusalem, Israel.
Isr Med Assoc J. 2011 Feb;13(2):84-6.
The age-standardized incidence rate of invasive cervical cancer in Israeli Jewish women is persistently low. Selected demographic characteristics of Israeli Jewish women with cervical squamous cell carcinoma (SCC) were reported recently.
To assess selected clinical characteristics of Israeli Jewish women with cervical SCC.
Included were all Israeli Jewish women with SCC diagnosed during the 3-year period 2002-2004. Data were obtained from the Israel National Cancer Registry and the Central Population Registry. Discharge summaries of the patients were reviewed and clinical data were abstracted.
The study was based on 350 israeli Jewish women with histologically confirmed cervical SCC diagnosed during the 3-year study period. The median age of the patients was 50.3 years. The most common main complaint was discharge/bleeding (35.7%) and only a small percentage (7.4%) was diagnosed subsequent to an abnormal cytological smear. The rate of patients diagnosed in stage I was 47.7%. The overall absolute 5-year survival and survival in stage I rates were 70% and 83.8% respectively. The rate of Israeli born patients diagnosed in stage I and their overall absolute 5-year survival was significantly higher than in the other ethnic groups.
Age, the most frequent main complaint, the percent of patients diagnosed in stage I and the 5-year survival (overall and in stage I) are similar to data in other countries. The survival rate of Israeli born women seems to be better than that of other ethnic groups.
以色列犹太女性浸润性宫颈癌的年龄标准化发病率一直较低。最近报道了以色列犹太女性宫颈鳞状细胞癌(SCC)的选定人口统计学特征。
评估以色列犹太女性宫颈SCC的选定临床特征。
纳入2002年至2004年3年期间诊断为SCC的所有以色列犹太女性。数据来自以色列国家癌症登记处和中央人口登记处。查阅患者的出院小结并提取临床数据。
该研究基于350名在3年研究期间经组织学确诊为宫颈SCC的以色列犹太女性。患者的中位年龄为50.3岁。最常见的主要症状是阴道分泌物/出血(35.7%),只有一小部分(7.4%)是在细胞学涂片异常后确诊的。I期诊断的患者比例为47.7%。总体绝对5年生存率和I期生存率分别为70%和83.8%。在I期诊断的以色列出生患者的比例及其总体绝对5年生存率显著高于其他种族群体。
年龄、最常见的主要症状、I期诊断的患者百分比以及5年生存率(总体和I期)与其他国家的数据相似。以色列出生女性的生存率似乎优于其他种族群体。